Cofactor Genomics
cofactorgenomics.comMatching cancer patients to treatment using the power of RNA
Health & Wellnessrna-seqgenomicsoncologyimmunotherapybiomarkerspredictive-diagnosticsprecision-medicine
About
Cofactor Genomics is a biotech company focused on predictive diagnostics for oncology, using RNA sequencing to match cancer patients to appropriate immunotherapy treatments. Their platform employs multidimensional biomarkers rather than single-analyte approaches to better predict patient response before treatment decisions are made. They offer sponsored research and clinical study programs for oncologists, pathologists, and clinical researchers.
Problem
Clinicians lack accurate tools to predict how cancer patients will respond to immunotherapy before treatment begins.
For
Medical oncologists, pathologists, and clinical researchers in immuno-oncology
How it works
The platform uses RNA sequencing and multidimensional biomarker models to generate predictive diagnostics about tumor response to immunotherapy.
Business model
unknown
Status
launched
Company
Cofactor Genomics